Cited by 349Neuroinflammation and Neurodegeneration MechanismsBarrier Structure and Function StudiesCerebrospinal fluid and hydrocephalus

The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus

Open access
Schwartz, Michal, Baruch, Kuti·2014·The EMBO Journal

Abstract

Inflammation is an integral part of the body's physiological repair mechanism, unless it remains unresolved and becomes pathological, as evident in the progressive nature of neurodegeneration. Based on studies from outside the central nervous system (CNS), it is now understood that the resolution of inflammation is an active process, which is dependent on well-orchestrated innate and adaptive immune responses. Due to the immunologically privileged status of the CNS, such resolution mechanism has been mostly ignored. Here, we discuss resolution of neuroinflammation as a process that depends on a network of immune cells operating in a tightly regulated sequence, involving the brain's choroid plexus (CP), a unique neuro-immunological interface, positioned to integrate signals it receives from the CNS parenchyma with signals coming from circulating immune cells, and to function as an on-alert gate for selective recruitment of inflammation-resolving leukocytes to the inflamed CNS parenchyma. Finally, we propose that functional dysregulation of the CP reflects a common underlying mechanism in the pathophysiology of neurodegenerative diseases, and can thus serve as a potential novel target for therapy.

Integrity signals

Registry

Crossref · 10.1002/embj.201386609

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Failure of inflammation resolution due to reduced production of SPMs is a reason leading to chronic inflammatory diseases.

    “Failure of resolution owing to the reduced production of SPMs is another reason that leads to chronic inflammatory diseases26”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [26]

  • BCSFB acts as a gateway for inflammation-resolving leukocyte entry into the CSF during immune responses through constitutively expressed adhesion molecules and chemokines in choroid plexus epithelial cells.

    “BCSFB acts as a gateway for inflammation-resolving leukocyte entry into the CSF during immune responses through the constitutively expressed adhesion molecules and chemokines in CP epithelial cells.”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [26]

  • CP acts as important neuro-immunological interface integrating signals from CNS parenchyma and circulating immune cells, and as on-alert gate for selective authorizing entry of inflammation-resolving leukocytes to inflamed CNS region.

    “In addition to secrete CSF, CP also acts as an important neuro-immunological interface that integrates signals from the CNS parenchyma and circulating immune cells. It also functions as an on-alert gate for selective authorizing the entry of inflammation-resolving leukocytes to the inflamed CNS region.26”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [26]

  • Failure of resolution is an important underlying cause of multiple chronic inflammatory diseases.

    “Failure of resolution is an important underlying cause of multiple chronic inflammatory diseases.26”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [26]

Cites

Flagged first, then by citations

2 of the 132 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Schwartz, M., & Baruch, K.
Affiliations
Weizmann Institute of Science (IL)
Corresponding author
Schwartz, Michal
Venue
The EMBO Journal
Published
2013-12-20
Volume
33
Issue
1
Pages
7-20
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2141330531
Cited by
349
References
132
Citations by year
2026: 18 · 2025: 25 · 2024: 24 · 2023: 31 · 2022: 29 · 2021: 35 · 2020: 28 · 2019: 35 · 2018: 22 · 2017: 20 · 2016: 33 · 2015: 33 · 2014: 16
FWCI
2.64
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Research Council (232835)
  • TargetBraIn (279017)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Cerebrospinal fluid and hydrocephalus
Keywords
neurodegeneration, choroid plexus, leukocyte recruitment, innate and adaptive immunity, neurodegenerative diseases, therapeutic target
MeSH terms
Animals, Brain Diseases, Choroid Plexus, Humans, Inflammation, Leukocytes, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review